Cargando…

Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor

BACKGROUND: Mesenchymal chondrosarcoma is an uncommon malignant variant of chondrosarcoma that mainly affects the bones and cartilaginous tissues, but may rarely involve the spine. Careful preoperative planning for surgical tumor removal and spine reconstruction is mandatory and must be based on onc...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehneh, Younes, Aldabbas, Mohannad, Elfarissi, Mohammed Alamine, Khoulali, Mohamed, Oulali, Noureddine, Moufid, Faycel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159291/
https://www.ncbi.nlm.nih.gov/pubmed/37151474
http://dx.doi.org/10.25259/SNI_206_2023
_version_ 1785037106274369536
author Dehneh, Younes
Aldabbas, Mohannad
Elfarissi, Mohammed Alamine
Khoulali, Mohamed
Oulali, Noureddine
Moufid, Faycel
author_facet Dehneh, Younes
Aldabbas, Mohannad
Elfarissi, Mohammed Alamine
Khoulali, Mohamed
Oulali, Noureddine
Moufid, Faycel
author_sort Dehneh, Younes
collection PubMed
description BACKGROUND: Mesenchymal chondrosarcoma is an uncommon malignant variant of chondrosarcoma that mainly affects the bones and cartilaginous tissues, but may rarely involve the spine. Careful preoperative planning for surgical tumor removal and spine reconstruction is mandatory and must be based on oncologic and surgical staging. CASE DESCRIPTION: Over 1 month, a 16-year-old female became paraplegic with a T9 sensory level and urinary dysfunction. The magnetic resonance imaging revealed an intraspinal extradural T7-T9 mass that was isointense in T1W1 and markedly enhanced with gadolinium. The patient underwent gross-total tumor resection followed by an osteoplastic laminectomy with fusion. The histological examination was consistent with a mesenchymal chondrosarcoma. She had received radiation and chemotherapy. One year later, she was readmitted for tumor recurrence with multiple metastases involving L1, the lung, and peritoneum. Despite full course of radiotherapy and chemotherapy, she died after 6 months of the second surgery. CONCLUSION: Total resection of mesenchymal chondrosarcomas is the gold standard for treatment and is typically followed by radiation and/or chemotherapy. However, the status of residual tumor, local extension, and or metastases best determine the overall survival which may prove extremely limited.
format Online
Article
Text
id pubmed-10159291
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Scientific Scholar
record_format MEDLINE/PubMed
spelling pubmed-101592912023-05-05 Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor Dehneh, Younes Aldabbas, Mohannad Elfarissi, Mohammed Alamine Khoulali, Mohamed Oulali, Noureddine Moufid, Faycel Surg Neurol Int Case Report BACKGROUND: Mesenchymal chondrosarcoma is an uncommon malignant variant of chondrosarcoma that mainly affects the bones and cartilaginous tissues, but may rarely involve the spine. Careful preoperative planning for surgical tumor removal and spine reconstruction is mandatory and must be based on oncologic and surgical staging. CASE DESCRIPTION: Over 1 month, a 16-year-old female became paraplegic with a T9 sensory level and urinary dysfunction. The magnetic resonance imaging revealed an intraspinal extradural T7-T9 mass that was isointense in T1W1 and markedly enhanced with gadolinium. The patient underwent gross-total tumor resection followed by an osteoplastic laminectomy with fusion. The histological examination was consistent with a mesenchymal chondrosarcoma. She had received radiation and chemotherapy. One year later, she was readmitted for tumor recurrence with multiple metastases involving L1, the lung, and peritoneum. Despite full course of radiotherapy and chemotherapy, she died after 6 months of the second surgery. CONCLUSION: Total resection of mesenchymal chondrosarcomas is the gold standard for treatment and is typically followed by radiation and/or chemotherapy. However, the status of residual tumor, local extension, and or metastases best determine the overall survival which may prove extremely limited. Scientific Scholar 2023-04-07 /pmc/articles/PMC10159291/ /pubmed/37151474 http://dx.doi.org/10.25259/SNI_206_2023 Text en Copyright: © 2023 Surgical Neurology International https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Dehneh, Younes
Aldabbas, Mohannad
Elfarissi, Mohammed Alamine
Khoulali, Mohamed
Oulali, Noureddine
Moufid, Faycel
Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor
title Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor
title_full Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor
title_fullStr Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor
title_full_unstemmed Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor
title_short Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor
title_sort spinal mesenchymal chondrosarcoma: a case report of a rare malignant tumor
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159291/
https://www.ncbi.nlm.nih.gov/pubmed/37151474
http://dx.doi.org/10.25259/SNI_206_2023
work_keys_str_mv AT dehnehyounes spinalmesenchymalchondrosarcomaacasereportofararemalignanttumor
AT aldabbasmohannad spinalmesenchymalchondrosarcomaacasereportofararemalignanttumor
AT elfarissimohammedalamine spinalmesenchymalchondrosarcomaacasereportofararemalignanttumor
AT khoulalimohamed spinalmesenchymalchondrosarcomaacasereportofararemalignanttumor
AT oulalinoureddine spinalmesenchymalchondrosarcomaacasereportofararemalignanttumor
AT moufidfaycel spinalmesenchymalchondrosarcomaacasereportofararemalignanttumor